Ascendis Pharma A/S (ASND)
240.65
+3.30
(+1.39%)
USD |
NASDAQ |
Mar 06, 16:00
241.00
+0.35
(+0.15%)
After-Hours: 20:00
Ascendis Pharma SG&A Expense (TTM) : 519.00M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Novo Nordisk A/S | 10.66B |
| Evaxion AS | 0.00 |
| DBV Technologies SA | 28.71M |
| Cellectis SA | 19.93M |
| Biodexa Pharmaceuticals Plc | 5.354M |